These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3071425)

  • 1. Enzyme immunoassay of human fibroblast interferon after intranasal administration with several excipients in rabbits.
    Igawa T; Maitani Y; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1988 Aug; 36(8):3055-9. PubMed ID: 3071425
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of absorption promoters in intranasal administration of human fibroblast interferon as a powder dosage form in rabbits.
    Igawa T; Maitani Y; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):418-21. PubMed ID: 2743486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal administration of beta-interferon in rabbits.
    Maitani Y; Igawa T; Machida Y; Nagai T
    Drug Des Deliv; 1986 Aug; 1(1):65-70. PubMed ID: 3509321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels following intranasal and intravenous administration of human interferon-beta to rabbits.
    Maitani Y; Igawa T; Machida Y; Nagai T
    Drug Des Deliv; 1989 Mar; 4(2):109-19. PubMed ID: 2765103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal administration of human fibroblast interferon in mice, rats, rabbits and dogs.
    Igawa T; Maitani Y; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):549-51. PubMed ID: 2337971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph.
    Bocci V; Pessina GP; Paulesu L; Nicoletti C
    J Biol Response Mod; 1988 Aug; 7(4):390-400. PubMed ID: 3171601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
    Rogge MC; Simonian NA; Jones WE
    Eur J Neurol; 1999 May; 6(3):375-7. PubMed ID: 10210923
    [No Abstract]   [Full Text] [Related]  

  • 8. What dose of intranasal interferon for the common cold?
    Herzog C; Berger R; Fernex M; Friesecke K; Havas L; Just M; Dubach UC
    Lancet; 1986 May; 1(8489):1089-90. PubMed ID: 2871352
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal interferon for contact prophylaxis against common cold in families.
    Herzog C; Just M; Berger R; Havas L; Fernex M
    Lancet; 1983 Oct; 2(8356):962. PubMed ID: 6138515
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits.
    Yu H; Kim K
    Int J Pharm; 2009 Aug; 378(1-2):73-9. PubMed ID: 19501141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and use of an immunoenzyme method for detecting interferon].
    Kiktenko AV
    Vopr Virusol; 1985; 30(2):242-4. PubMed ID: 2988214
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal vaccination: pharmaceutical evaluation of the vaccine delivery system and immunokinetic characteristics of the immune responses.
    Gizurarson S; Aggerbeck H; Gudmundsson M; Heron I
    Pharm Dev Technol; 1998 Aug; 3(3):385-94. PubMed ID: 9742559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Namalva interferon-alpha monoclonal antibodies for purification and enzyme immunoassay of interferon-alpha.
    Notani J; Kaizu T; Mutoh S; Otsuka K; Kusunoki C; Yamada H; Nagayoshi A; Suzuki S; Niwa M; Ueda I
    J Immunoassay; 1989; 10(2-3):257-76. PubMed ID: 2473094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans.
    Treanor JJ; Betts RF; Erb SM; Roth FK; Dolin R
    J Infect Dis; 1987 Aug; 156(2):379-83. PubMed ID: 3598236
    [No Abstract]   [Full Text] [Related]  

  • 16. Highly sensitive enzyme immunoassay of human interferon-beta 1.
    Yamazaki S; Kuramoto K; Matsuo E; Hosoi K; Hara M; Shimizu H
    J Immunoassay; 1989; 10(1):57-73. PubMed ID: 2654186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphatic route. IX. Distribution of recombinant interferon-alpha 2 administered subcutaneously with oedematogenic drugs.
    Pessina GP; Bocci V; Carraro F; Naldini A; Paulesu L
    Physiol Res; 1993; 42(4):243-50. PubMed ID: 8280722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of alpha 2-interferon against the common cold.
    Foy HM; Fox JP; Cooney MK
    N Engl J Med; 1986 Aug; 315(8):513-4. PubMed ID: 3736634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electron microscope study of plasma cells in rat regional lymph nodes after local administration of interferon].
    Maĭborodin IV; Borodin IuI; Gavrilin VN; Grigor'ev VN
    Biull Eksp Biol Med; 1996 Jul; 122(7):60-3. PubMed ID: 9303704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with using reaferon in the complex treatment of patients with brucellosis].
    Kurmanova KB; Saltykov VP; Aspetov RZh
    Ter Arkh; 1989; 61(2):119-20. PubMed ID: 2727911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.